TNF-alpha inhibition for the treatment of cardiac sarcoidosis

摘要

Background: Tumor necrosis factor alpha (TNF-alpha) inhibitors are increasingly being used for treating refractory cardiac sarcoidosis. There is a theoretical risk, however, that these therapies can worsen heart failure, and reports on efficacy and safety are lacking.